ESMO World Congress on Gastrointestinal Cancer 2017

Oncology Meeting Resources

28 Jun - 01 Jul 2017, Barcelona, Spain

ESMO World GI 2017 square image

The ESMO World Congress on Gastrointestinal Cancer 2017 (World GI) is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.

Abstracts, presentations and webcasts are open access. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Watch the ESMO scientific videos

Best Abstracts Session on Colorectal Cancer, Speaker: Filippo Pietrantonio

Tips for Practice: MSI Testing in GI Cancers, Speaker: Fatima Carneiro

Prevention of Colorectal Cancer, Speaker: Nadir Arber

The Role of Microbiome in Cancer Medicine, Speaker: James Godaert

All interviews from the event on the ESMO Channel





Format available

https://oncologypro.esmo.org/Meeting-Resour...r-2017/Treatment-of-recurrent-gastric-cancer

Recurrence of gastric cancer is severe health condition that is associated with poor prognosis and limited treatment possibilities. Many physicians consider that recurrent gastric cancer is incurable...

Date: 28 Jun 2017
Presenter: Guntis Ancans
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...n-patients-with-metastatic-pancreatic-cancer

nab-Paclitaxel plus gemcitabine is a preferred treatment for patients with metastatic pancreatic cancer and good performance status. An early, single-center study of patients with advanced pancreatic...

Date: 28 Jun 2017
Presenter: Vaibhav Sahai
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...features-prognosis-and-influence-on-survival

Gastric cancer(GC) is the fourth most common malignancy worldwide with an estimated 1000000 new cases annually and is the second leading cause of cancer-related deaths.

Date: 28 Jun 2017
Presenter: Navneet Mishra Anchal
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...y-tract-cancer-A-multi-disease-phase-1-study

Angiogenesis and immunosuppression are implicated in the pathogenesis and progression of invasive biliary tract cancers, including adenocarcinomas of the gallbladder, intra- and extra- hepatic cholangiocarcinoma, and Ampulla of Vater.

Date: 28 Jun 2017
Presenter: Johanna Bendell
Resources: Abstract
Topics: Gastrointestinal Cancers, Hepatobiliary Cancers, Immunotherapy, Therapy

https://oncologypro.esmo.org/Meeting-Resour...tatic-pancreatic-cancer-patients-MazoviaGI-1

Pancreatic cancer is the fourth leading cause of cancer death worldwide with a poor prognosis and majority of patients presenting with unresectable disease. Gemcitabine has been considered the primary...

Date: 28 Jun 2017
Presenter: Agnieszka Kolasinska-Cwikła
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...yps-in-a-population-based-case-control-study

Colorectal cancer (CRC) is common and a leading cause of cancer-related death, which develops gradually from adenomatous and serrated polyps. Established dietary risk factors for CRC include high intake...

Date: 28 Jun 2017
Presenter: Shira Zelver-Sagi
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...mach-cancer-after-adjuvant-radiochemotherapy

Although insufficiency fractures occurring in acetabulum and sacrum following pelvic radiotherapy (PR) are well known, decrease in bone mineral density (BMD) developing in vertebral bones after pelvic...

Date: 28 Jun 2017
Presenter: Gökhan Yaprak
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...tric-cancer-patients-after-radical-resection

Evaluate the predictive value of the preoperative blood lymphocyte-to-monocyte ratio (LMR) on the clinical outcomes of patients with gastric cancer(GC) after radical surgery.

Date: 28 Jun 2017
Presenter: Jianxian Lin
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...atients-with-gastric-cancer-Can-we-do-better

The effects of preoperative malnutrition and PCH on the short- and long-term outcomes in patients with gastric cancer are unclear.

Date: 28 Jun 2017
Presenter: Jun Lu
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...-from-eastern-Algeria-with-colorectal-cancer

Cancer is increasingly a major public health problem in Algeria, where the number of cases and the proportions vary from one region to another (the East: 28%). Colorectal cancer is the third most common cancer in Algeria both sexes combined.

Date: 28 Jun 2017
Presenter: Djedi Hanene
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon and Rectal Cancer